Literature DB >> 3029445

Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984.

B M Nkowane, S G Wassilak, W A Orenstein, K J Bart, L B Schonberger, A R Hinman, O M Kew.   

Abstract

From 1973 through 1984, there were 138 cases of paralytic poliomyelitis reported in the United States; 105 (76%) were vaccine associated. Of the 105 vaccine-associated cases, 35 occurred in recipients of oral polio vaccine (OPV), 50 in contacts to OPV recipients, 14 in immune deficient individuals, and six in individuals who had no history of receiving OPV or contact with recent OPV recipients. Thirty-three (94%) of the recipient cases, 41 (82%) of the contact cases, and five (36%) of the immune deficient cases were associated with the first dose of OPV. The overall frequency of vaccine-associated poliomyelitis was one case per 2.6 million doses distributed. However, the relative frequency of paralysis associated with the first dose in the OPV series was one case per 520,000 doses vs one case per 12.3 million subsequent doses. Vaccine-associated paralytic poliomyelitis is rare and the risks of OPV are small. The greatest likelihood of paralysis occurs in association with the first dose of OPV and that likelihood is reduced in subsequent doses more for recipients than for their contacts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029445

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  53 in total

1.  Neurovirulence of type 1 polioviruses isolated from sewage in Japan.

Authors:  Hitoshi Horie; Hiromu Yoshida; Kumiko Matsuura; Miwako Miyazawa; Yoshihiro Ota; Takashi Nakayama; Yutaka Doi; So Hashizume
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

2.  MRI in poliomyelitis-like syndrome.

Authors:  H Wakamoto; T Morimoto; H Nagao; H Matsuda
Journal:  Pediatr Radiol       Date:  1992

Review 3.  Poliomyelitis: eradication in sight.

Authors:  J L Melnick
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

4.  1889 to 1989: a century of health and disease.

Authors:  A R Hinman
Journal:  Public Health Rep       Date:  1990 Jul-Aug       Impact factor: 2.792

Review 5.  Primary prevention and international travel: infections, immunizations, and antimicrobial prophylaxis.

Authors:  G S Ferenchick; D H Havlichek
Journal:  J Gen Intern Med       Date:  1989 May-Jun       Impact factor: 5.128

6.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.

Authors:  T Tulchinsky; Y Abed; S Shaheen; N Toubassi; Y Sever; M Schoenbaum; R Handsher
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

8.  A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.

Authors:  Minetaro Arita; Shuang-Li Zhu; Hiromu Yoshida; Tetsuo Yoneyama; Tatsuo Miyamura; Hiroyuki Shimizu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; F Delpeyroux; M Tardy-Panit; J Balanant; M Combiescu; A A Combiescu; S Guillot; R Crainic
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction.

Authors:  M F Bachmann; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.